To evaluate the relationship between inflammatory markers and is due to IkB␣ phosphorylation, polyubiquitinylation, and severity of asthma in children, the amount of interleukin-8 (IL-8) rapid degradation by proteasome. As a result, NF-B transloand granulocyte/macrophage colony-stimulating factor (GM-CSF)
examined whether the in vitro production of IL-8 and GM-CSF by these cells was sensitive to pyrrolidinedithiocarbamate, The identification of biomarkers measured using non-or minian inhibitor of NF-B activation (17). Finally, to better characmally invasive methods represents an important goal in the terize the activation of NF-B pathway, we analyzed the exmanagement of childhood asthma for several reasons. First, pression of p65 NF-B subunit and of the phosphorylated inflammatory and structural changes of the airways occur very form of IkB␣ (p-IkB␣) in PBMC of the study groups. Finally, early in asthma; second, the long-term management of childthe biological parameters examined were correlated with the hood asthma is still debated (1) (2) (3) ; third the risk/benefit ratio number of exacerbations occurring during a follow-up period of a prolonged treatment with high steroid doses can be probof 18 months. lematic (4-6); fourth, clinical subpopulations exist in children with severe asthma (7) . The persistence of airway inflammation METHODS in asthma is likely to be due to the sustained transcription and production of inflammatory mediators. Among transcription Subjects factors, nuclear factor-B (NF-B) plays an important role in Twenty-nine asthmatics (6-14 years, mean Ϯ SD: 9.6 Ϯ 2.3) were reairway inflammation (8) (9) (10) and activates the transcription of cruited from an outpatient clinic. The diagnosis of asthma and the several genes. NF-B activation is inhibited by endogenous assessment of its severity were done at study entry according to Global cytoplasmic inhibitors, known as IkBs. The most characterized Initiative for Asthma 1995 (18). Twelve children had intermittent asthma, NF-B inhibitor is IkB␣, which binds avidly to the p65 (RelA) treated with short-acting ␤2 agonists on demand during the last 6 subunit of NF-B, precluding its nuclear translocation and months preceding the study; 17 children had moderate persistent transcriptional activity. The dissociation of IkB␣ from NF-B asthma, treated with fluticasone propionate 250 mg (inhaler device Diskus [GlaxoSmithKline, London, UK]) plus salmeterol 50 g twice daily for at least 6 months before their inclusion in the study. The control group consisted of six healthy children (7-11 years, mean Ϯ SD: 9.5 Ϯ 1.3). The study was approved by our local ethics committee, (Received in original form June 12, 2002 ; accepted in final form January 28, 2003) and written consent was obtained from parents.
Correspondence and requests for reprints should be addressed to A. Maurizio Vignola, M.D., Ph.D., Istituto di Medicina Generale e Pneumologia, Università di and specific IgE to aeroallergens commonly present in the Palermo were quantified by enzyme-linked immunosorbent assay (R&D Systems, Oxon, UK) after the end of the study. area. The compliance to the therapy was assessed by checking the inhalation technique at every visit. We also measured in the three study Nitric Oxide Measurement groups basal plasma cortisol concentration at 8:00 a.m. (22, 23) by electrochemiluminescence (24) , at study entry and at the end of the follow-FE NO was determined by chemiluminescence (Sievers Instruments up period. Results were expressed in nanomolar concentrations, and Inc, Boulder, CO, USA) and measured in triplicate after fast inhalation adherence was considered satisfactory if cortisol was less than 100 nM. maneuvers to total lung capacity, at a constant expiratory flow of 100 ml/ seconds against an expiratory resistance of 20 cm water (25) .
Production of Cytokines by PBMC
Western Blotting PBMC isolated by Ficoll-Hypaque gradient centrifugation were cultivated as described previously (13) in the absence or presence of pyrrolidinediWestern blot analyses were performed as described previously (13). thiocarbamic acid. All supernatants were stored at Ϫ80ЊC, and cytokines
Study Design
This was a study in which several biomarkers (IL-8 and GM-CSF released by PBMC, p65 and p-IkB␣ protein level in PBMC, and FE NO) were measured in 29 children with asthma at study entry; these markers were then correlated with asthma control assessed longitudinally by the number of exacerbations during a follow-up period of 18 months. After a month of run-in period, during which FEV 1 before and after bronchodilatation (400 g of salbutamol) was assessed, patients attended the out-patient clinic (visit 1) and underwent clinical assessment (pre-and postbronchodilator FEV 1 ) at 3, 6, 12, and 18 months by the same physician (S.L.G.), who was unaware of the results on biomarker measurements. During the follow-up period, mild and severe exacerbations were defined, according to the Formoterol and Corticosteroids Establishing Therapy study (26) . At the beginning of the study, the parents were instructed to refer to our center if any exacerbation occurred. Severe exacerbations were treated with a short course of oral steroids (1 mg/kg of prednisolone for 5 days).
Statistical Analysis
Nonparametric tests were used.
RESULTS

Patient Characteristics
All asthmatic children were monosensitized to house dust mites ( Table 1) . Evidence of satisfactory adherence to therapy was obtained in all but one patient, who was excluded from the followup analysis.
GM-CSF and IL-8 Production
GM-CSF production by PBMC was similar in children with moderate and intermittent asthma and significantly higher than in children in the control group (p Ͻ 0.001) ( Figure 1A ). IL-8 release by PBMC was higher in childen with moderate asthma than in children with intermittent asthma and children in the control group (p Ͻ 0.002 and p Ͻ 0.0001, respectively) ( Figure 1B ). Within the moderate asthmatic group, two distinct subgroups of children were observed according to the levels of GM-CSF and IL-8: one (low producers) characterised by a low release of both mediators by PBMC (IL8 Ͻ 1,100 ng/ml; GM-CSF Ͻ 19 pg/ml); another subgroup (high producers) characterised by a high release of both mediators (IL8 Ͼ 1,100 ng/ml; GMCSF Ͼ 19 pg/ml). In the figure, closed triangles show low producers moderate persistent asthmatics whereas open triangles show high producers moderate persistent asthmatics. Closed circles: child with noncompliant moderate persistent asthma. Statistical analysis and p values were assessed without including the noncompliant subject. 
with Moderate Asthma Correlation between Biomarkers and Asthma Exacerbations
Two distinct subgroups of children with moderate asthma were In patients with moderate asthma, there were 39 exacerbations observed: low producers, characterized by low mediator release (mean 2.2 exacerbations per patient), of which 31 were moderate (IL-8 Ͻ 1,100 pg/ml; GM-CSF Ͻ 19 pg/ml) ( Figures 1A and 1B) and eight severe. Three out of 17 patients did not have any and low FE NO levels (Ͻ 20 ppb) ( Figure 1C) , and high producers, exacerbation. IL-8, GM-CSF, and FE NO levels were significharacterized by a high mediator release and high FE NO levels cantly correlated with the number of exacerbations (p Ͻ 0.004, (IL-8 Ͼ 1,100 pg/ml; GM-CSF Ͼ 19 pg/ml; FE NO Ͼ 20 ppb) p Ͻ 0.004, and p Ͻ 0.002) (Figure 6 ). In addition, high producers ( Figures 1A-1C) . Pyrrolidinedithiocarbamate treatment inhibited IL-8 release by 52% for high producers and 32% for low produchad a significantly higher number of exacerbations (3.2/patient/ ers, and GM-CSF release by 40% for high producers and 24% year) than low producers (1/patient/year) (p Ͻ 0.002). Moreover, for low producers (p Ͻ 0.001) (Figure 2 ). In high producers (but only high producers experienced severe exacerbations. Likewise, not in low producers) postbronchodilator FEV 1 significantly dian increased number of exacerbations was observed in three minished by the end of the study (p Ͻ 0.005) (Figure 3) . children with intermittent asthma who showed increased production of IL-8 and GM-CSF by PBMC as well as enhanced FE
Protein Levels of NF-B p65 Subunit and p-IkB␣ Protein
NO levels. Finally, the levels of cortisol were similar in high and The relative amount of p65 and p-IkB␣ protein was higher in low producers and did not significantly correlate with the levels children with moderate asthma than in children with intermittent of the biomarkers studied.
DISCUSSION
This study shows that the levels of several biomarkers, such as IL-8 and GM-CSF released by PBMC as well as NF-B, p-IkB␣ were assessed without including the noncompliant subject.
and FE NO, are significantly higher in children with intermittent likely that a number of these patients may fall into the category and moderate persistent asthma than in healthy control children.
of "steroid insensitive" because despite the high dose of inhaled In addition, this study suggests that two different subgroups of corticosteroid they are still having relapses and require courses children with moderate asthma can be identified according to the of oral corticosteroid. levels of biomarkers measured. Although inhaled corticosteroids This study also shows that in some patients, at recommended are highly effective in children with asthma, some patients are doses, inhaled corticosteroids do not completely inhibit all innot fully controlled, probably because of an ongoing inflammaflammatory cellular and molecular mechanisms underlying airtion. We therefore designed this pilot study to assess longitudiway inflammation. In some patients with moderate persistent nally asthma control in children with moderate asthma and to investigate the predictive value of several inflammatory biomarkers measured at study entry. In addition, to avoid any bias due to lack of adherence to treatment, compliance was assessed by measuring the levels of cortisol (5, 7, 24) in children with both by PBMC as well as the levels of NF-B, p-IkB␣, and FE NO may be useful to assess clinical heterogeneity in children with the overexpression of p65 subunit. On inflammatory activation, IkB␣ is phosphorylated and proteolyzed, resulting in release of moderate asthma. This study also proposes the need to perform large prospective studies to confirm the importance of measuring NF-B dimers from the cytoplasmic NF-B/IkB complex and translocation to the nucleus. The de novo synthesis of IkB␣ after peripheral blood markers to assess airway inflammation and asthma control in children with asthma. degradation inhibits NF-B in the absence of a new signal (27). Enhanced IkB␣ phosphorylation, observed in some children with asthma, suggests that resynthesized IkB␣ is constantly phos-
